No definition available.
Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)
C3_CLL_EXALLC
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
969 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
969 |
4. Check minimum number of eventsNone |
969 |
5. Include endpoints |
969 |
6. Filter based on genotype QC (FinnGen only) |
969 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
- Control conditions
- not HLP_C3_CLL
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Chronic lymphocytic leukaemia, helper endpoint
- Chronic lymphocytic leukaemia
- Any event in cancer register
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 969 | 340 | 629 |
| Unadjusted period prevalence (%) | 0.22 | 0.12 | 0.28 |
| Median age at first event (years) | 67.94 | 67.08 | 68.40 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 878
- Matched controls
- 8781
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
160.1
323.0
453
58
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
323.0
748
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
323.0
776
*
XW000
NOMESCO Finland
Bone marrow biopsy
45.8
258.0
319
108
A04AA01
ATC
ondansetron; systemic, rectal
54.9
185.5
220
53
L03AA02
ATC
filgrastim; parenteral
247.3
178.5
178
9
JN4BD
NOMESCO Finland
Extensive body CT
15.2
137.7
242
214
L01BB05
ATC
fludarabine; systemic
+∞
137.1
128
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
765.4
136.6
131
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
744.8
133.3
128
*
L01AA02
ATC
chlorambucil; oral
1425.9
129.6
123
*
M04AA01
ATC
allopurinol; systemic
7.1
128.8
390
893
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
125.0
117
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
73.5
121.1
137
22
L03AA13
ATC
pegfilgrastim; parenteral
657.3
119.1
115
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
13.3
118.0
219
213
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
75.0
109.0
123
19
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
108.6
102
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
541.0
99.6
97
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.6
92.6
274
564
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
131.3
88.9
94
8
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
243.9
87.1
88
*
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
86.9
82
*
390
Kela drug reimbursment
Ibrutinib
+∞
85.8
81
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
84.8
80
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
231.7
82.9
84
*
1512
Kela drug reimbursment
Ibrutinib
+∞
80.4
76
*
WW500
NOMESCO Finland
Blood transfusion
19.3
75.9
118
70
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
166.0
73.2
76
5
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
102.3
69.1
75
8
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
67.6
64
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
67.6
64
*
ZX120
NOMESCO Finland
Intravenous
7.5
66.5
170
273
B73
ICPC
Leukaemia
354.0
65.4
65
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
64.4
61
*
399
Kela drug reimbursment
Venetoclax
+∞
64.4
61
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
19.0
64.2
100
59
JN4AD
NOMESCO Finland
Body CT examination
10.7
63.9
129
139
R50.9
ICD-10 Finland
Fever, unspecified
4.9
61.8
232
598
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
10.7
61.5
124
133
A04AA02
ATC
granisetron; systemic, transdermal
137.8
60.7
64
5
H02AB02
ATC
dexamethasone; systemic
26.1
59.2
83
35
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
61.2
58.5
68
12
L01AA01
ATC
cyclophosphamide; systemic
55.6
56.8
67
13
116
Kela drug reimbursment
Prostate cancer
+∞
53.7
51
*
L01XX52
ATC
venetoclax; oral
+∞
53.7
51
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.2
53.5
155
291
PJA10
NOMESCO Finland
Exploration of lymph nodes
121.7
53.5
57
5
1XC02
NOMESCO Finland
NA
65.4
53.1
61
10
A03FA01
ATC
metoclopramide; systemic, rectal
4.8
52.7
196
492
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
52.5
201
520
J05AB11
ATC
valaciclovir; oral
4.6
51.7
201
528
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
49.6
504
2772
130
Kela drug reimbursment
Malignant tumour
+∞
48.4
46
*
JN6AD
NOMESCO Finland
CT of torso and neck
59.6
48.1
56
10
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
493.1
47.8
47
*
L01EL01
ATC
ibrutinib; oral
+∞
45.2
43
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
45.2
43
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
42.0
40
*
1518
Kela drug reimbursment
NA
+∞
42.0
40
*
ZX108
NOMESCO Finland
Inhalation
42.2
38.8
48
12
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
36.7
35
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
35.7
34
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
35.4
339
1687
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
34.6
33
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
79.4
34.1
38
5
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
79.4
34.1
38
5
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
33.5
32
*
J01MA12
ATC
levofloxacin; systemic
3.0
33.4
235
963
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
46.4
33.0
40
9
L57.0
ICD-10 Finland
Actinic keratosis
4.2
32.8
135
363
C90.0
ICD-10 Finland
Multiple myeloma
328.2
32.1
32
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
117.7
31.9
34
*
J01MA14
ATC
moxifloxacin; systemic
4.0
31.6
136
381
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
31.5
259
1164
372
Kela drug reimbursment
Idelalisib
+∞
31.4
30
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
165.7
30.9
32
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
165.7
30.9
32
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
30.4
29
*
115
Kela drug reimbursment
Breast cancer
+∞
30.4
29
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
30.4
29
*
ZX112
NOMESCO Finland
Subcutaneous
22.0
30.3
44
21
WF002
NOMESCO Finland
Radical radiotherapy
110.5
29.8
32
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.6
29.8
79
129
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
17.0
29.6
47
29
212
Kela drug reimbursment
Gout
7.1
29.5
74
112
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
29.3
28
*
L01XX47
ATC
[U] idelalisib; oral
+∞
29.3
28
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
301.3
28.9
29
*
2041A
ICD-9 Finland
Lymphoid leukaemia, Chronic
+∞
28.3
27
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
103.4
27.8
30
*
1AA09
NOMESCO Finland
NA
+∞
27.2
26
*
TQW99
NOMESCO Finland
Other minor procedure on skin
6.8
27.0
70
111
L02BB03
ATC
bicalutamide; oral
279.0
26.9
27
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
99.8
26.8
29
*
Z51.5
ICD-10 Finland
Palliative care
7.2
26.6
66
98
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
38.0
26.3
33
9
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
26.2
25
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
62.0
26.1
30
5
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
51.6
25.4
30
6
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
25.1
24
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.3
24.3
48
49
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
+∞
24.1
23
*
ZZR00
NOMESCO Finland
Flap of skin
17.8
23.3
36
21
D70.89
ICD-10 Finland
Neutropenic splenomegaly
20.7
23.1
34
17
C91
ICD-10 Finland
Lymphoid leukaemia
+∞
23.0
22
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
23.0
22
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
22.9
419
2693
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.3
22.2
70
142
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.4
22.0
68
135
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.1
21.7
60
104
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
21.6
220
1079
J05AB01
ATC
aciclovir; systemic
2.4
20.9
212
1034
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.9
20
*
H02AB06
ATC
prednisolone; systemic
2.0
20.0
439
2972
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
36.7
19.9
25
7
L02BG04
ATC
letrozole; oral
+∞
19.9
19
*
WZC30
NOMESCO Finland
Teaching
3.2
19.8
112
386
JN4CD
NOMESCO Finland
Very extensive body CT
7.9
19.3
44
58
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
13.1
19.0
33
26
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
56.3
19.0
22
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
18.8
18
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
18.8
18
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
18.8
18
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
18.8
18
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
193.8
18.6
19
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.7
18.5
140
581
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
30.8
18.4
24
8
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.1
18.2
72
185
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.9
18.0
117
442
XX3DW
NOMESCO Finland
Time consuming IT work
4.1
18.0
73
192
TGC00
NOMESCO Finland
Bronchial lavation
5.8
17.8
51
93
A04AD12
ATC
aprepitant; systemic
+∞
17.8
17
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
17.8
17
*
L01BC06
ATC
capecitabine; oral
+∞
17.8
17
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
17.8
17
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
183.4
17.6
18
*
H02AB07
ATC
prednisone; oral
2.5
17.2
153
691
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.9
17.1
36
42
A02BC02
ATC
pantoprazole; systemic
1.9
16.9
556
4233
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.1
16.9
68
178
WW200
NOMESCO Finland
Immunization
5.8
16.8
48
87
Y77
ICPC
Malignant neoplasm prostate
64.6
16.8
19
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
16.7
16
*
C91.7
ICD-10 Finland
Other lymphoid leukaemia
173.0
16.5
17
*
B01AB10
ATC
tinzaparin; parenteral
4.0
15.9
64
168
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
15.7
60
150
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
15.7
15
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
15.7
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.7
15
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
15.7
15
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
162.7
15.5
16
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.5
14.9
72
220
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
15.4
14.9
24
16
6BA02
NOMESCO Finland
NA
32.3
14.8
19
6
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
32.3
14.8
19
6
A79
ICPC
Malignancy NOS
57.7
14.8
17
*
N02AA05
ATC
oxycodone; systemic
2.4
14.7
130
583
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
14.6
14
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
14.6
14
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
14.6
14
*
HA1AA
NOMESCO Finland
X-ray mammography
6.6
14.6
37
58
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
9.1
14.5
30
34
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
152.3
14.5
15
*
B02.9
ICD-10 Finland
Zoster without complication
3.1
14.4
82
283
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
14.0
276
1735
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.7
13.8
47
105
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
13.7
117
517
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
13.6
13
*
1CX01
NOMESCO Finland
NA
+∞
13.6
13
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
34.6
13.5
17
5
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
142.0
13.5
14
*
ZXC50
NOMESCO Finland
Cryotherapy
5.7
13.4
38
69
HAB40
NOMESCO Finland
Wedge excision of mammary gland
18.6
13.4
20
11
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
11.2
13.1
24
22
J01CA04
ATC
amoxicillin; systemic
1.8
13.1
624
5118
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
19.4
12.9
19
10
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
12.9
84
318
B01AB05
ATC
enoxaparin; parenteral
1.8
12.7
252
1579
J01DB01
ATC
cefalexin; oral
1.8
12.7
656
5479
B74
ICPC
Malignant neoplasm blood other
70.9
12.6
14
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
12.5
12
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
131.7
12.5
13
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
131.7
12.5
13
*
D06BB10
ATC
imiquimod; topical
4.3
12.5
46
112
J02AC03
ATC
voriconazole; systemic
47.3
11.9
14
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
14.9
11.8
19
13
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
11.6
254
1636
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
11.5
11
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
11.5
11
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
11.5
11
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.5
11
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
11.5
11
*
L02BA01
ATC
tamoxifen; oral
121.5
11.4
12
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.9
11.4
31
54
ZXC15
NOMESCO Finland
Use of photodynamic technique
12.0
11.4
20
17
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
11.2
193
1145
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.5
11.1
89
377
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.5
11.0
25
34
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.6
10.7
47
135
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
60.7
10.6
12
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
60.7
10.6
12
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.6
10.5
46
132
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
111.2
10.4
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.4
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
10.4
10
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
10.4
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.4
10
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
10.4
10
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
10.4
10
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.4
10
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
10.4
10
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
7.8
10.4
23
30
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
23.7
10.3
14
6
S18
ICPC
Laceration/cut
1.6
10.0
349
2541
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
9.8
89
402
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.1
9.8
30
61
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
9.8
89
405
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.4
9.7
28
53
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.9
9.7
60
220
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
9.7
75
315
GD1AD
NOMESCO Finland
Thorax CT examination
3.4
9.6
46
142
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
3.8
9.4
38
102
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
X76
ICPC
Malignant neoplasm breast female
+∞
9.4
9
*
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
+∞
9.4
9
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
9.4
9
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
9.4
9
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
9.4
9
*
B72
ICPC
Hodgkin Lymphoma
+∞
9.4
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
9.4
9
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
6.0
9.1
24
41
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.3
9.1
32
76
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
15.8
9.0
14
9
B02
ICPC
Lymph gland(s) enlarged/painful
15.8
9.0
14
9
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
18.8
8.9
13
7
R4110
NOMESCO Finland
Physiotherapy
1.7
8.9
204
1318
B99
ICPC
Blood/lymph/spleen disease other
14.2
8.7
14
10
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
50.5
8.7
10
*
WX402
NOMESCO Finland
General anaesthesia
2.1
8.7
102
520
R4190
NOMESCO Finland
Nutritional therapy
5.3
8.7
25
48
A03
ICPC
Fever
2.1
8.6
98
494
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
27.8
8.5
11
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
20.2
8.5
12
6
WX892
NOMESCO Finland
Monitored bed care
2.3
8.5
80
369
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
90.8
8.4
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
90.8
8.4
9
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
90.8
8.4
9
*
B03XA01
ATC
erythropoietin; parenteral
6.8
8.4
20
30
3AA02
NOMESCO Finland
NA
+∞
8.3
8
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
8.3
8
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
8.3
8
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
8.3
8
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
8.3
8
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.3
8
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.3
8
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
8.3
8
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
8.3
8
*
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.9
8.3
15
14
ZXC20
NOMESCO Finland
Use of chemical agents
5.8
8.2
22
39
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
8.0
129
740
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
7.8
50
190
S77
ICPC
Malignant neoplasm of skin
15.2
7.7
12
8
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
45.4
7.7
9
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
8.1
7.6
16
20
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.3
7.6
37
117
ZXC96
NOMESCO Finland
Robot assisted procedure
12.0
7.6
13
11
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
7.6
88
447
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
25.2
7.6
10
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.9
7.5
43
151
WX110
NOMESCO Finland
Local anesthesy
1.5
7.5
473
3870
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
80.7
7.4
8
*
B59
ICD-10 Finland
Pneumocystosis
80.7
7.4
8
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
80.7
7.4
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
7.4
124
726
J12.8
ICD-10 Finland
Other viral pneumonia
8.5
7.3
15
18
9823/3-C77.0
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
7.3
7
*
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
+∞
7.3
7
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
7.3
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
7.3
7
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.3
7
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.3
7.3
25
59
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.6
7.1
17
26
R31
ICD-10 Finland
Unspecified haematuria
1.9
7.0
98
537
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
7.0
52
215
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
5.2
7.0
20
39
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.8
6.9
44
164
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
6.9
32
98
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
13.9
6.9
11
8
J35.1
ICD-10 Finland
Hypertrophy of tonsils
8.3
6.8
14
17
EMA10
NOMESCO Finland
Biopsy of tonsil
40.3
6.8
8
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
40.3
6.8
8
*
ZZA50
NOMESCO Finland
Full thickness skin graft
40.3
6.8
8
*
EBA10
NOMESCO Finland
Surgical removal of tooth
2.2
6.7
67
320
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
6.7
101
566
S29
ICPC
Skin symptom/complaint other
1.7
6.7
138
860
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
12.3
6.6
11
9
UKC02
NOMESCO Finland
Cystoscopy
1.7
6.6
143
904
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
6.6
281
2102
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
70.3
6.4
7
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
70.3
6.4
7
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
6.4
55
246
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
6.4
146
936
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
6.4
64
307
S59
ICPC
Skin, Other therap proced/minor surg NEC
6.6
6.3
15
23
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.3
268
1995
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
11.1
6.3
11
10
122
Kela drug reimbursment
Aplastic anaemia
18.2
6.3
9
5
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
+∞
6.3
6
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
B84
ICPC
Unexplained abnormal white cells
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
6.3
6
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
6.3
6
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.3
6
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
6.3
6
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.3
6
*
ZQZ00
NOMESCO Finland
Treatment of several skin areas
26.9
6.2
8
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
26.9
6.2
8
*
A02BC01
ATC
omeprazole; systemic
1.5
6.2
236
1715
B03XA02
ATC
darbepoetin alfa; parenteral
3.8
6.2
24
64
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
6.2
122
748
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.5
6.1
26
75
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
6.1
155
1023
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
8.7
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
219
93
30.13
315.31
4.4
6.0
601.18
508.53
iu/ml
0.08
34
15
230
84
35.59
307.65
8.1
3.0
0.23
1.47
%
1.80
184
59
253
110
30.77
307.65
1.5
1.5
—
—
—
0
0
383
190
32.68
307.65
2.8
1.4
—
—
—
0
0
510
768
12.91
307.65
9.2
2.3
71.08
67.57
e9/l
1.13
398
597
699
797
28.89
307.65
16.1
2.7
230.12
241.78
u/l
1.95
679
743
504
442
22.68
307.65
4.4
2.1
7.81
11.02
g/l
25.05
481
404
601
1017
13.93
307.65
8.2
2.1
1.75
1.79
%
0.38
567
884
320
386
11.88
261.45
3.4
1.6
1.23
1.53
g/l
5.08
282
329
178
71
30.49
260.76
2.2
2.5
3062.61
308.80
u/ml
—
18
10
152
40
44.88
252.03
2.5
1.3
—
—
—
0
0
152
40
44.88
252.03
2.5
1.3
—
—
—
0
0
289
358
11.08
229.69
2.0
1.3
1.15
1.19
g/l
0.06
249
330
319
506
8.91
206.26
11.1
3.6
0.13
0.56
%
2.21
210
96
322
531
8.58
200.85
11.6
3.7
0.06
0.06
%
0.04
266
117
785
3179
8.74
191.41
18.9
5.4
1.58
3.00
%
69.42
759
2913
786
3190
8.75
191.09
20.7
5.6
6.06
8.96
%
63.36
759
2933
786
3243
8.54
185.83
19.7
5.5
54.99
26.21
%
143.26
758
2963
764
3088
7.97
184.03
17.9
5.3
0.41
0.67
%
31.97
738
2832
131
66
22.79
173.81
8.1
3.0
28.95
56.50
%
9.00
76
44
599
2052
6.03
170.15
9.6
2.6
765.83
8111.41
umol/l
7.07
571
1715
759
3217
7.27
167.70
16.7
5.4
35.40
58.40
%
132.77
729
2960
102
34
33.41
157.01
2.7
2.1
23.92
42.39
%
2.44
24
12
96
27
39.36
155.17
2.6
1.5
542.31
1059.18
e6/l
1.36
36
11
122
79
17.52
143.48
1.1
1.4
106.16
106.87
u/ml
—
19
9
134
0
+∞
143.37
1.3
0.0
—
—
—
0
0
751
3570
5.91
132.32
19.1
5.2
0.17
0.21
e9/l
8.35
692
3084
301
691
5.87
130.67
2.3
1.6
63.94
66.94
g/l
6.26
286
616
740
3499
5.72
130.55
15.5
5.2
12.56
1.81
e9/l
31.06
686
3035
776
3829
6.15
129.42
29.9
5.9
3.40
4.47
e9/l
38.77
733
3286
746
3598
5.66
126.97
15.2
3.8
12.32
12.50
umol/l
0.18
729
3356
172
251
8.12
115.95
2.1
1.3
0.05
0.02
g/l
0.38
163
229
73
22
35.80
115.28
2.0
3.1
—
—
—
0
0
112
92
13.63
114.92
1.2
1.1
—
—
—
0
0
74
25
31.96
112.90
1.8
2.8
10.19
14.38
%
—
21
8
180
286
7.50
112.34
2.2
1.4
0.77
0.51
g/l
0.62
165
240
346
1010
4.77
111.09
8.6
4.6
1.08
1.02
mmol/l
4.77
332
915
132
148
10.17
109.82
2.8
1.4
—
—
—
0
0
136
159
9.79
109.65
2.7
1.4
—
—
—
0
0
106
88
13.40
107.94
1.2
1.2
360.56
278.45
u/ml
0.96
52
44
185
317
6.98
107.36
2.1
1.4
2.98
3.12
g/l
1.00
158
247
161
238
7.91
107.02
2.2
1.3
0.00
0.00
g/l
0.50
153
217
191
346
6.63
104.87
2.1
1.4
—
—
—
0
0
191
346
6.63
104.87
2.1
1.4
3.09
3.95
g/l
6.51
158
245
191
346
6.63
104.87
2.1
1.4
6.68
7.45
g/l
6.27
158
250
158
235
7.84
104.37
2.2
1.3
0.00
0.00
g/l
0.00
153
216
166
275
7.08
99.17
2.1
1.3
39.24
37.30
g/l
3.07
156
227
181
328
6.56
99.09
2.1
1.4
8.28
10.62
g/l
7.51
163
273
82
50
17.82
98.78
1.5
1.7
—
—
—
0
0
107
109
10.91
95.10
2.9
1.5
—
—
—
0
0
338
1080
4.27
94.41
3.5
2.4
0.82
0.82
mmol/l
0.05
321
984
337
1108
4.13
89.92
1.8
1.3
1.69
2.90
g/l
8.88
282
631
111
139
8.89
84.30
1.2
1.3
—
—
—
0
0
684
3809
3.71
77.85
13.3
5.5
1.21
1.21
mmol/l
0.38
598
3195
145
270
6.14
76.47
3.3
3.1
—
—
—
0
0
79
6
143.15
75.15
1.3
1.2
—
—
—
0
0
51
19
28.28
74.97
7.4
1.9
—
—
—
0
0
242
705
4.24
74.91
4.5
2.3
8.81
9.31
umol/l
0.09
229
611
96
121
8.70
72.32
1.7
1.3
—
—
—
0
0
634
3489
3.36
70.90
11.8
5.1
1.21
1.21
mmol/l
0.06
604
3061
349
1351
3.47
70.53
3.2
1.8
—
—
—
0
0
597
3201
3.25
69.18
7.0
3.8
34.74
35.03
g/l
0.52
568
2931
40
11
37.89
64.25
3.4
1.1
—
—
—
0
0
286
1031
3.52
63.88
2.8
2.5
23.24
22.85
%
0.16
251
860
39
10
40.59
63.77
1.9
4.1
—
—
—
0
0
80
94
9.19
63.58
2.0
1.5
—
—
—
0
0
81
99
8.84
62.40
1.7
1.3
—
—
—
0
0
292
1099
3.37
60.49
2.7
2.4
2.23
2.25
g/l
0.16
278
1007
66
66
10.66
59.00
3.5
1.3
—
—
—
0
0
67
72
9.92
56.87
3.5
1.3
—
—
—
0
0
44
23
19.99
56.53
1.4
1.4
—
—
—
0
0
261
960
3.35
55.62
2.5
1.8
—
—
—
0
0
261
961
3.35
55.51
2.6
1.8
—
—
—
0
0
77
105
7.88
54.09
1.9
1.3
—
—
—
0
0
298
1205
3.13
53.96
2.8
2.3
13.27
12.73
umol/l
0.52
285
1091
801
5564
3.54
51.72
21.3
5.4
83.22
77.92
u/l
2.84
778
5091
63
72
9.29
51.01
1.8
1.7
—
—
—
0
0
58
60
10.22
50.54
3.7
1.1
—
—
—
0
0
58
60
10.22
50.54
3.7
1.1
—
—
—
0
0
58
60
10.22
50.54
3.7
1.2
—
—
—
0
0
86
147
6.32
48.96
1.4
1.5
—
—
—
0
0
68
93
7.79
47.57
1.9
1.3
—
—
—
0
0
84
146
6.20
47.00
1.4
1.1
120.39
18.42
u/l
1.45
76
129
117
274
4.72
46.98
2.1
1.5
31.47
55.32
mg/l
0.59
107
222
359
1712
2.74
46.89
6.2
3.6
83.15
81.56
%
0.56
351
1660
117
275
4.70
46.76
2.2
1.5
62.56
48.37
mg/l
0.75
108
222
536
3146
2.57
45.20
7.9
3.7
—
—
—
0
0
129
348
4.12
43.04
2.3
1.7
1.02
1.69
ug/l
0.63
113
300
339
1642
2.64
42.12
4.8
2.1
—
—
—
0
0
70
114
6.54
41.70
8.3
2.9
30.13
59.64
%
19.12
70
114
38
29
13.60
40.16
4.7
1.1
—
—
—
0
0
38
29
13.60
40.16
4.7
1.1
—
—
—
0
0
38
29
13.60
40.16
4.7
1.1
—
—
—
0
0
38
29
13.60
40.16
4.6
1.1
—
—
—
0
0
157
518
3.42
38.83
1.9
1.5
—
—
—
0
0
32
19
17.38
38.58
5.3
1.1
—
—
—
0
0
32
19
17.38
38.58
5.3
1.1
—
—
—
0
0
32
19
17.38
38.58
5.3
1.1
—
—
—
0
0
479
2830
2.37
37.57
3.9
2.7
451.61
150.37
ug/l
1.58
440
2540
378
2039
2.40
36.20
2.7
2.2
4.06
2.96
mg/l
6.18
332
1696
132
408
3.59
36.01
3.4
1.4
8.55
3.70
ug/l
0.58
100
305
59
96
6.48
35.12
1.6
1.5
30.53
25.93
g/l
1.63
53
86
267
1242
2.59
35.12
2.3
1.8
29.40
30.05
s
0.95
257
1198
653
4546
2.34
33.10
7.1
4.4
6.83
6.94
mmol/l
0.65
639
4256
414
2397
2.27
32.86
4.8
2.1
2.34
2.35
mmol/l
0.69
365
1933
398
2282
2.26
32.18
3.8
3.1
43.08
91.52
e6/l
0.93
325
1765
25
13
19.71
31.91
1.0
1.3
—
—
—
0
0
32
27
12.22
31.77
2.7
1.4
—
—
—
0
0
54
90
6.30
31.38
1.3
1.3
—
—
—
0
0
46
65
7.38
31.16
2.5
2.2
—
—
—
0
0
24
12
20.48
31.13
1.3
1.0
—
—
—
0
0
24
13
18.91
30.06
1.8
1.3
—
—
—
0
0
450
2770
2.17
29.90
3.8
3.1
—
—
—
0
0
36
40
9.31
29.62
1.2
1.1
—
—
—
0
0
35
8
45.27
28.84
1.1
2.0
—
—
—
0
0
86
231
3.99
28.60
1.6
1.3
—
—
—
0
0
32
32
10.31
28.39
2.0
1.8
5707.31
1327.41
u/ml
1.77
32
32
75
187
4.26
27.55
1.7
1.4
—
—
—
0
0
75
187
4.26
27.55
1.7
1.4
—
—
—
0
0
50
88
5.94
27.49
1.7
1.5
1952.61
1711.25
e6/l
0.15
41
61
47
79
6.20
27.06
1.7
1.6
91998.03
112832.13
e6/l
0.08
31
45
358
2090
2.13
26.51
3.7
3.0
0.38
0.53
e6/l
0.88
289
1583
26
21
12.69
26.44
1.5
1.2
—
—
—
0
0
717
5450
2.21
25.69
6.4
4.1
13.96
13.36
mm/h
0.35
675
4947
164
692
2.65
25.63
5.9
5.6
10.73
11.26
mmol/l
0.41
156
649
137
533
2.83
25.03
2.0
1.6
—
—
—
0
0
26
23
11.59
24.98
1.4
1.1
—
—
—
0
0
287
1602
2.12
23.38
3.2
2.4
3.94
4.62
e6/l
0.69
254
1396
54
128
4.41
21.14
1.3
1.3
—
—
—
0
0
27
32
8.65
21.09
1.0
1.2
—
—
—
0
0
644
4881
1.95
20.77
5.5
4.5
880.33
1791.11
e6/l
0.38
12
76
340
2103
1.95
20.31
1.9
1.6
20.83
20.45
nmol/l
0.17
310
1745
336
2070
1.95
20.31
5.8
2.6
37.47
35.09
u/l
0.33
325
1955
27
35
7.91
19.62
1.9
1.5
—
—
—
0
0
36
67
5.54
18.65
1.2
1.2
171.17
142.09
miu/ml
—
6
19
17
12
14.40
18.52
1.1
1.1
—
—
—
0
0
29
44
6.76
18.38
1.8
1.4
—
—
—
0
0
26
35
7.61
18.30
2.0
1.3
—
—
—
0
0
131
582
2.45
18.09
1.8
1.9
0.19
0.19
g/l
0.22
118
516
26
36
7.39
17.87
2.0
1.3
—
—
—
0
0
217
1195
2.05
17.71
3.1
2.8
1.71
2.02
e6/l
0.28
126
650
41
90
4.71
17.64
3.0
4.3
—
—
—
0
0
25
35
7.31
17.01
1.9
1.5
—
—
—
0
0
471
3369
1.77
16.80
11.4
11.2
1.30
1.40
inr
1.42
127
927
24
33
7.43
16.58
11.0
1.2
202.00
204.45
u/l
0.07
24
33
51
140
3.79
16.41
1.2
1.1
—
—
—
0
0
30
53
5.81
16.41
2.1
1.5
—
—
—
0
0
248
1468
1.93
16.31
1.8
1.6
1.90
1.28
mg/l
1.00
206
1136
63
202
3.27
16.02
1.8
1.6
—
—
—
0
0
125
575
2.35
15.90
2.1
2.1
34.19
33.84
u/l
0.04
115
460
270
1657
1.87
15.83
3.8
4.2
338.72
491.93
ng/l
0.42
235
1428
486
3548
1.74
15.80
2.6
2.1
93.83
92.61
pmol/l
0.22
303
1830
84
324
2.74
15.44
4.7
1.7
—
—
—
0
0
23
33
7.11
15.31
3.1
3.7
—
—
—
0
0
63
208
3.17
15.28
1.4
1.5
0.03
0.15
iu/ml
1.21
19
49
141
695
2.20
15.20
8.0
6.1
1.11
1.49
mmol/l
6.40
136
670
79
302
2.76
14.77
2.9
1.6
—
—
—
0
0
14
0
+∞
14.62
1.1
0.0
—
—
—
0
0
113
530
2.28
13.69
4.3
3.5
4.99
5.15
kpa
1.23
99
486
178
995
1.97
13.63
9.1
6.0
104.25
104.37
mmol/l
0.13
171
969
237
1455
1.83
13.61
4.3
2.2
2.45
2.45
mmol/l
0.07
215
1241
27
53
5.21
13.21
1.1
1.2
65.28
53.39
u/l
0.44
18
36
20
29
7.02
13.17
2.3
1.3
—
—
—
0
0
20
29
7.02
13.17
2.3
1.3
—
—
—
0
0
216
1300
1.85
13.17
3.1
2.6
0.92
1.39
e6/l
0.76
125
750
28
57
5.03
13.16
1.1
1.0
—
—
—
0
0
107
502
2.27
12.94
1.6
1.5
—
—
—
0
0
16
5
32.49
12.59
1.0
3.0
—
—
—
0
0
389
2812
1.64
12.11
3.0
3.0
1902.06
1668.35
ng/l
0.48
355
2422
105
503
2.22
12.07
4.4
3.5
1.98
1.81
mmol/l
0.17
77
369
47
152
3.20
11.81
1.7
1.2
—
—
—
0
0
22
40
5.60
11.68
2.1
6.2
—
35.91
—
0
11
30
72
4.27
11.59
1.1
1.1
—
—
—
0
0
16
7
23.21
11.59
3.6
1.3
—
—
—
0
0
16
7
23.21
11.59
1.4
1.0
—
—
—
0
0
438
3294
1.60
11.40
2.9
2.2
—
—
—
0
0
57
211
2.81
11.33
2.6
3.1
24.63
25.04
mmol/l
0.27
45
183
68
276
2.57
11.30
1.8
2.0
42.23
39.65
u/l
0.36
62
234
19
31
6.23
11.23
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
271
2.58
11.22
3.4
2.6
0.36
0.35
u/ml
0.05
43
158
167
976
1.86
11.03
8.0
6.5
1.15
1.23
mmol/l
0.11
133
751
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
33
5.85
10.56
1.2
1.1
—
—
—
0
0
812
7175
1.81
10.50
41.8
14.5
26.35
26.16
mg/l
0.06
751
5679
11
10
11.11
10.17
1.3
1.2
—
—
—
0
0
164
979
1.81
10.06
8.5
6.5
4.91
5.08
kpa
1.30
158
934
163
979
1.80
9.79
8.5
6.4
11.32
11.41
kpa
0.07
157
932
111
592
1.99
9.60
1.9
1.7
421.66
362.30
nmol/l
2.42
104
528
30
86
3.57
9.13
2.5
1.8
19.83
61.55
u/ml
0.99
25
77
140
820
1.83
9.10
3.7
3.1
2.06
2.08
mmol/l
0.01
110
659
47
177
2.74
9.08
2.7
2.8
7.62
7.80
kpa
0.36
38
162
13
7
18.80
8.94
1.2
1.1
—
—
—
0
0
27
74
3.72
8.77
2.1
1.2
—
—
—
0
0
27
75
3.67
8.60
2.2
1.2
—
—
—
0
0
41
148
2.85
8.58
1.3
1.6
—
—
—
0
0
261
1835
1.58
8.52
2.0
1.8
1161.12
1173.54
nmol/l
0.07
201
1366
27
76
3.63
8.44
2.2
1.2
—
—
—
0
0
27
76
3.63
8.44
2.1
1.2
—
—
—
0
0
27
77
3.58
8.29
2.2
1.2
—
—
—
0
0
310
2287
1.52
8.08
2.4
2.3
55.66
58.70
u/l
0.67
285
2083
140
849
1.76
8.07
2.6
3.1
234.19
244.74
ng/l
0.11
124
788
661
5685
1.51
8.02
50.4
17.4
14.67
13.78
%
34.02
653
5520
29
90
3.29
7.85
1.2
1.1
—
—
—
0
0
115
667
1.82
7.69
1.5
1.3
—
—
—
0
0
513
4216
1.46
7.67
3.1
3.0
52.82
52.32
u/l
0.04
466
3789
26
77
3.44
7.56
2.2
1.2
—
—
—
0
0
42
165
2.62
7.51
2.9
2.3
13.36
16.06
%
2.23
19
81
16
33
4.91
7.42
1.1
1.0
—
—
—
0
0
16
33
4.91
7.42
1.6
1.2
—
—
—
0
0
13
22
5.98
7.39
1.2
1.1
—
—
—
0
0
13
22
5.98
7.39
1.2
1.1
—
—
—
0
0
11
16
6.94
7.16
1.2
1.1
176.84
1.37
ug/l
—
6
6
10
5
20.18
7.14
1.0
1.4
—
—
—
0
0
20
53
3.83
6.83
1.1
1.2
—
—
—
0
0
30
106
2.89
6.57
1.3
1.3
—
—
—
0
0
370
2922
1.43
6.52
2.1
2.2
83.88
79.09
nmol/l
2.47
327
2496
15
34
4.47
6.25
1.5
1.4
1.67
12.80
u/l
—
9
15
30
110
2.78
6.16
1.4
1.1
—
—
—
0
0
64
330
2.01
6.11
5.4
3.9
25.30
24.78
mmol/l
0.69
57
300
10
8
12.61
6.09
1.2
1.3
—
—
—
0
0
12
23
5.27
6.02
1.1
1.1
—
—
—
0
0
693
6169
1.43
5.87
42.5
16.2
37.42
39.14
%
4.32
451
3724
11
20
5.55
5.81
1.2
1.1
—
—
—
0
0
28
104
2.74
5.63
2.4
1.7
89.26
89.82
%
0.25
28
104
43
199
2.21
5.45
2.9
1.5
1.10
1.14
g/l
0.31
43
191
8
5
16.12
5.41
2.0
1.6
1.63
2.20
%
—
8
5
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
11
23
4.83
5.02
1.2
1.1
—
—
—
0
0
14
36
3.93
5.00
1.3
1.2
—
—
—
0
0
25
96
2.65
4.75
4.0
6.9
10.63
12.41
mg/l
1.05
17
91
38
179
2.17
4.65
2.5
2.1
107.69
131.24
g/l
4.04
26
135
7
5
14.09
4.58
1.0
1.0
—
—
—
0
0
9
11
8.25
4.56
1.0
1.1
—
—
—
0
0
20
70
2.90
4.51
1.1
1.2
—
—
—
0
0
21
76
2.80
4.47
1.1
1.2
1.67
1.57
u/ml
—
6
21
12
31
3.91
4.26
1.0
1.2
—
—
—
0
0
174
1289
1.43
4.14
23.7
30.9
1.51
1.46
inr
0.15
33
181
7
7
10.06
4.01
1.0
1.3
—
—
—
0
0
35
171
2.09
3.95
1.4
1.7
—
—
—
0
0
92
604
1.58
3.93
7.2
2.5
1.22
1.22
mmol/l
0.47
87
501
8
11
7.32
3.86
1.1
1.3
—
—
—
0
0
732
6749
1.35
3.82
36.1
13.6
72.20
72.95
ml/min/173m2
0.49
664
5445
116
807
1.50
3.81
4.7
3.1
—
—
—
0
0
8
12
6.71
3.68
1.3
1.3
—
—
—
0
0
9
17
5.33
3.51
1.1
1.1
—
—
—
0
0
6
6
10.05
3.50
1.3
1.3
—
—
—
0
0
7
10
7.04
3.36
1.0
1.0
—
—
—
0
0
9
19
4.77
3.24
2.1
4.1
—
—
—
0
0
18
72
2.53
3.22
1.1
1.2
1.83
7.17
u/ml
—
6
35
12
38
3.18
3.22
1.1
1.1
—
—
—
0
0
10
28
3.60
3.20
1.0
1.1
—
—
—
0
0
59
369
1.64
3.11
1.4
1.2
24.45
253.23
u/ml
9.60
39
335
40
226
1.80
3.03
3.5
3.3
0.78
0.81
nmol/l
0.12
26
176
75
502
1.54
2.99
1.4
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
13
5.41
2.87
1.0
2.3
196.47
173.92
%
—
7
13
810
7673
1.34
2.87
27.7
9.4
24.05
25.48
u/l
2.11
792
7274
14
53
2.67
2.80
1.1
1.0
—
—
—
0
0
814
7725
1.34
2.78
39.8
17.9
139.44
139.73
mmol/l
2.11
798
7487
411
3609
1.24
2.76
3.9
3.7
0.00
0.00
estimate
0.00
83
609
5
6
8.37
2.75
1.2
1.3
—
—
—
0
0
15
60
2.52
2.71
1.4
1.5
173.87
68.03
pmol/l
0.67
15
60
6
10
6.03
2.70
1.3
1.0
—
—
—
0
0
20
92
2.20
2.68
1.2
1.3
15.67
6.37
u/l
1.92
14
75
9
24
3.77
2.67
1.2
1.0
—
—
—
0
0
814
7741
1.32
2.61
43.4
18.0
4.04
4.01
mmol/l
2.74
795
7492
381
3336
1.23
2.58
4.2
4.1
172.43
72.37
ng/l
0.33
313
2563
5
7
7.17
2.55
1.0
1.1
1.96
1.60
umol/l
—
5
7
69
471
1.50
2.54
1.9
2.3
11.04
15.30
nmol/l
3.11
55
410
408
3605
1.23
2.52
5.4
5.0
0.00
0.00
estimate
0.00
87
606
669
7118
0.81
2.45
4.4
4.9
1.26
1.42
mmol/l
16.30
595
6401
82
1124
0.70
2.41
12.5
7.3
—
—
—
0
0
410
3657
1.21
2.24
3.9
3.8
0.04
0.01
estimate
0.40
85
591
16
74
2.18
2.15
1.0
1.1
—
—
—
0
0
681
7200
0.82
2.14
4.4
4.9
4.27
4.41
mmol/l
2.59
608
6522
84
623
1.38
2.03
3.0
3.6
79.00
93.80
ng/l
1.50
72
534
703
7387
0.82
1.93
5.0
5.6
2.56
2.55
mmol/l
0.12
625
6672
667
7037
0.83
1.87
6.0
6.7
39.06
41.19
mmol/mol
8.01
591
6416
9
34
2.66
1.86
1.4
1.3
—
—
—
0
0
9
35
2.59
1.80
1.3
1.0
—
—
—
0
0
11
48
2.31
1.71
1.8
1.7
12.73
15.11
umol/l
0.56
11
43
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
17
90
1.90
1.66
1.5
1.3
—
—
—
0
0
292
2596
1.18
1.55
1.8
2.2
153.28
279.01
u/l
1.86
268
2423
657
6899
0.85
1.54
4.0
4.4
1.31
1.29
mmol/l
0.36
584
6140
28
178
1.59
1.50
1.4
1.4
235.57
295.81
ug/g
0.93
19
107
42
295
1.44
1.44
2.3
3.0
4.10
4.41
pmol/l
1.55
34
246
16
88
1.83
1.42
1.6
1.2
0.69
0.67
nmol/l
0.08
16
81
817
7912
1.21
1.35
59.4
21.3
124.12
135.46
g/l
60.08
804
7728
176
2030
0.84
1.34
1.6
1.6
1.42
1.33
mmol/l
0.66
147
1654
6
24
2.51
1.30
1.2
2.8
—
—
—
0
0
6
24
2.51
1.30
1.2
2.8
—
—
—
0
0
816
7910
1.20
1.28
59.2
21.2
190.52
237.43
e9/l
54.36
800
7620
816
7911
1.20
1.28
59.1
21.2
4.13
4.46
e12/l
42.93
798
7588
816
7912
1.20
1.27
59.2
21.2
20.85
6.87
e9/l
42.57
797
7591
0
35
0.00
1.15
0.0
2.0
—
50.08
—
0
24
87
1057
0.81
1.14
1.2
1.2
26.94
14.31
u/ml
0.32
19
356
228
2039
1.15
1.11
2.8
2.8
0.79
0.77
ug/l
0.09
170
1428
38
279
1.38
1.07
4.0
4.2
3.92
3.93
mmol/l
0.04
33
261
43
325
1.34
1.02
4.0
3.9
1.24
1.47
mmol/l
0.85
43
318
17
260
0.65
0.98
2.2
2.3
90.42
64.17
ug/min
—
9
153
393
3671
1.12
0.96
4.9
4.0
10.39
2.15
ug/l
0.51
352
3271
708
7303
0.89
0.91
5.6
5.1
6.05
6.14
mmol/l
1.39
639
6489
22
154
1.44
0.84
1.2
1.3
6.13
60.45
e6/l
0.84
16
127
263
2845
0.90
0.80
4.0
4.1
16.14
7.94
mg/mmol
0.97
172
1831
93
1079
0.85
0.80
1.3
1.3
43.19
42.20
iu/ml
0.03
29
334
557
5338
1.10
0.79
3.6
3.6
15.14
15.09
pmol/l
0.16
494
4706
11
66
1.67
0.79
1.2
1.1
—
61.63
—
0
8
17
115
1.49
0.77
2.7
2.3
4.15
4.13
mmol/l
0.09
17
115
17
115
1.49
0.77
2.7
2.3
104.88
105.23
mmol/l
0.14
17
115
15
99
1.52
0.76
1.0
1.3
—
—
—
0
0
25
334
0.74
0.74
2.0
1.8
—
—
—
0
0
38
303
1.26
0.67
1.0
1.2
158.83
107.06
iu/ml
—
10
117
15
214
0.70
0.66
1.3
1.5
—
—
—
0
0
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
176
1922
0.90
0.64
1.8
1.8
268613578.73
19313450.89
pmol/l
0.64
137
1543
8
49
1.64
0.62
1.6
1.4
1.12
0.93
g/l
—
8
49
0
20
0.00
0.60
0.0
1.1
—
232.25
—
0
12
20
150
1.34
0.56
1.5
1.5
—
—
—
0
0
159
1727
0.91
0.54
4.3
4.1
1.02
1.02
kg/l
0.56
18
265
52
604
0.85
0.50
1.6
1.7
1.63
1.61
%
0.05
42
496
14
190
0.73
0.50
1.2
1.4
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
95
1050
0.89
0.46
4.3
5.1
29.45
32.96
%
1.95
60
673
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
676
6625
1.07
0.41
4.5
4.5
2.27
2.03
mu/l
2.65
609
5876
24
195
1.24
0.40
1.2
1.1
—
—
—
0
0
24
196
1.23
0.39
1.2
1.1
—
—
—
0
0
10
72
1.39
0.37
1.1
1.3
—
—
—
0
0
12
90
1.34
0.36
1.1
1.0
—
—
—
0
0
6
44
1.37
0.34
3.0
2.3
—
—
—
0
0
6
47
1.28
0.32
1.2
2.2
—
—
—
0
0
67
609
1.11
0.31
3.5
2.4
61.97
59.47
ml/min/173m2
0.30
40
255
29
249
1.17
0.31
1.4
1.2
—
—
—
0
0
308
2985
1.05
0.26
4.3
3.9
21.99
24.25
%
1.68
153
1492
5
39
1.28
0.23
2.4
1.1
—
—
—
0
0
5
39
1.28
0.23
2.4
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
209
2018
1.05
0.21
4.3
4.1
0.00
0.01
estimate
0.50
85
578
134
1280
1.05
0.21
1.2
1.2
4.41
1.72
u/ml
0.31
15
341
261
2683
0.96
0.19
3.2
3.3
1219.54
168.01
mg/l
1.41
171
1723
25
222
1.13
0.19
2.8
1.9
—
—
—
0
0
6
52
1.15
0.19
1.2
1.1
—
—
—
0
0
14
121
1.16
0.15
1.1
1.9
3.04
4.51
iu/l
—
5
43
22
240
0.91
0.11
1.0
1.0
—
—
—
0
0
22
236
0.93
0.08
1.4
1.3
—
—
—
0
0
90
878
1.03
0.07
2.2
2.5
5.32
7.85
ug/l
0.94
72
766
9
100
0.90
0.06
3.4
4.3
371.11
343.78
umol/l
—
9
85
269
2719
0.99
0.06
3.2
3.2
7.27
7.50
mmol/l
0.41
225
2257
277
2783
0.99
0.02
4.5
4.0
—
—
—
0
0
10
96
1.04
0.00
1.9
1.4
—
—
—
0
0
17
173
0.98
0.00
4.3
3.6
28.08
26.14
mg/l
0.08
11
116
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
25.98
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_CLL_EXALLC – Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)
GWS hits: 13
This endpoint is excluded (different definition than used in FinnGen).